Xenotransplantation of human lymphoid malignancies is optimized in mice with multiple immunologic defects (original) (raw)

Biotechnical Methods Section (BTS)

Leukemia volume 12, pages 2029–2033 (1998)Cite this article

Abstract

While it is known that mice with genetic immune defects are useful for establishing durable engraftment of human tumor xenografts, the relative role of components of host innate and adoptive immunity in engraftment has not been determined. We directly compared the ability of four strains of genetically immunodeficient mice (NOD/SCID, SCID, Nude and Rag-1-deficient) to successfully engraft and support the human cell lines Daudi, Raji, Namalwa and Molt-4 as subcutaneous tumors. We additionally examined the effect of further immunosuppression of the mice by whole body irradiation at a dose of 600 cGy for Nude and Rag-1 and 300 cGy for SCID mice and by administration of anti-natural killer (asialo-GM1) antibody on tumor growth. Mice with each of the defects supported xenografts to varying degrees. We found differences in growth characteristics in the cell lines tested, with Namalwa consistently producing the largest tumors. With all cell lines studied, optimal growth was achieved using NOD/SCID mice. Overall, tumor growth was somewhat enhanced by pretreatment with radiation with little additional benefit from the addition of anti-asialo-GM1 antibody. The importance of multiple components of the innate and adoptive immune system in xenotransplantation were best demonstrated when results in untreated NOD/SCID mice were compared to SCID, nude and RAG-1-deficient mice. The NOD/SCID mouse with or without additional immunosuppression provides the optimal model for the study of the biology and treatment of human leukemias and lymphomas.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Departments of Pediatrics and Laboratory Medicine/Pathology, Cancer Center, University of Minnesota, Minneapolis, MN, USA
    WA Hudson, Q Li & JH Kersey
  2. Division of Biostatistics, University of Minnesota, Minneapolis, MN, USA
    C Le

Authors

  1. WA Hudson
    You can also search for this author inPubMed Google Scholar
  2. Q Li
    You can also search for this author inPubMed Google Scholar
  3. C Le
    You can also search for this author inPubMed Google Scholar
  4. JH Kersey
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Hudson, W., Li, Q., Le, C. et al. Xenotransplantation of human lymphoid malignancies is optimized in mice with multiple immunologic defects.Leukemia 12, 2029–2033 (1998). https://doi.org/10.1038/sj.leu.2401236

Download citation

Keywords

This article is cited by